To Newsroom

Oriola-KD Corporation completes its Swedish pharmacy chain acquisition


Oriola-KD Corporation Stock Exchange Release 19 February 2010 at 12.30 a.m.

Kronans Droghandel Retail AB, a company jointly owned by Oriola-KD Corporation
(80 per cent ownership) and Kooperativa Förbundet (20 per cent ownership) has
completed the acquisition of 100 per cent of the shares of Pharmacy Company
Sweden 2 AB, a nation wide pharmacy cluster with 171 pharmacies, net sales of
some EUR 430 million and 930 employees.

The conditions precedent for closing have been fulfilled and Kronans Droghandel
Retail AB has received approval by the Swedish Competition Authority
(Konkurrensverket) and been granted pharmacy licences by the Swedish Medical
Products Agency (Läkemedelsverket). The final purchase price of the acquisition
is EUR 161.0 million (SEK 1.59 billion) in cash.

The acquired company will be consolidated into Oriola-KD's financials as of 19
February 2010. Oriola-KD will publish Proforma 2009 figures and provisional
details on the net assets and purchase price allocation for the pharmacy cluster
acquisition in its January-March 2010 interim report.

"Entering the pharmaceutical retail business in Sweden is an important part of
Oriola-KD's strategy to expand the operations from pharmaceutical wholesale to
retail. After long and careful preparations we are fully prepared to take over
the nation wide pharmacy chain and to further develop and expand the operations
as a leading pharmacy company in Sweden", said Eero Hautaniemi, President and
CEO, Oriola-KD Corporation.

Oriola-KD Corporation

Eero Hautaniemi
President and CEO

Kimmo Virtanen
Executive Vice President and CFO

Further information:

Kimmo Virtanen
Executive Vice President and CFO
tel. +358 (0)10 429 2069

Pellervo Hämäläinen
Vice President, Communications and IR
Tel.+358 (0)10 429 2497

NASDAQ OMX Helsinki Ltd.
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
02200 Espoo